GlassScriptPhysician profile
Robert Harris Mondschein
NPI 1174523880
$20,411.94
in general payments reported to CMS, 2019-2025
17 companies · $333 in 2025
The $333 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,024 · 2020: $316 · 2021: $1,125 · 2022: $17K · 2023: $661 · 2024: $294 · 2025: $333.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,287.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Triad Life Sciences INC. | $15,760.00 | 2022 | |
| Smith+Nephew, INC. | $2,806.44 | 2019-2025 | Collagenase Santyl, Regranex |
| Abbvie INC. | $548.74 | 2022-2024 | |
| Organogenesis INC. | $417.41 | 2019-2023 | Puraply |
| Misonix INC | $170.67 | 2020-2021 | |
| Medline Industries LP | $160.98 | 2025 | |
| Kci USA, INC. | $151.47 | 2019-2020 | |
| Urgo Medical North America, LLC | $134.95 | 2025 | Urgok2 |
| Convatec INC. | $74.33 | 2021 | |
| Kerecis Limited | $46.63 | 2020 | |
| Paratek Pharmaceuticals, INC. | $35.92 | 2024-2025 | Nuzyra |
| Abbott Laboratories | $19.80 | 2019 | |
| Neurocrine Biosciences, INC. | $17.91 | 2022 | |
| Lundbeck LLC | $17.31 | 2023 | Vyepti |
| Hydrofera LLC | $16.98 | 2023 | Hydrofera Blue |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $16.43 | 2022 | |
| Tei Medical INC. | $15.97 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Mondschein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.